Biotech Values

[Regulardoc]

Or perhaps missing the cash receivable from NVS after the fourth quarter 2010 numbers reported.

On a side note, just started a patient on enoxaparin 100mg prefilled syringe this morning for DVT. Was a Sandoz label, but a bit disppointed that the package did not cantain a glossy instructional sheet for the patient. Would cost all of $.25 and would be nice for patients.